ATE269858T1 - Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan - Google Patents

Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan

Info

Publication number
ATE269858T1
ATE269858T1 AT00126032T AT00126032T ATE269858T1 AT E269858 T1 ATE269858 T1 AT E269858T1 AT 00126032 T AT00126032 T AT 00126032T AT 00126032 T AT00126032 T AT 00126032T AT E269858 T1 ATE269858 T1 AT E269858T1
Authority
AT
Austria
Prior art keywords
losartan
crystalline
acid addition
addition salt
purifying
Prior art date
Application number
AT00126032T
Other languages
English (en)
Inventor
Tadashi Katsura
Nishiyodogawa-Ku
Hiroshi Shiratani
Nobushige Itaya
Original Assignee
Sumika Fine Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumika Fine Chemicals Co Ltd filed Critical Sumika Fine Chemicals Co Ltd
Application granted granted Critical
Publication of ATE269858T1 publication Critical patent/ATE269858T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00126032T 1999-12-06 2000-11-29 Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan ATE269858T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34682999 1999-12-06
JP2000282853A JP2001226372A (ja) 1999-12-06 2000-09-19 ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法

Publications (1)

Publication Number Publication Date
ATE269858T1 true ATE269858T1 (de) 2004-07-15

Family

ID=26578371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00126032T ATE269858T1 (de) 1999-12-06 2000-11-29 Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan

Country Status (6)

Country Link
US (1) US6350880B1 (de)
EP (1) EP1106611B1 (de)
JP (1) JP2001226372A (de)
AT (1) ATE269858T1 (de)
DE (1) DE60011739T2 (de)
ES (1) ES2218051T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2482857A1 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
US7271269B2 (en) * 2003-01-30 2007-09-18 Lek Pharmaceuticals D.D. Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
KR101202209B1 (ko) * 2004-12-14 2012-11-19 교린 세이야꾸 가부시키 가이샤 무스카린 수용체 길항 작용약의 제조방법 및 이의 중간체
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
SI2176253T1 (sl) * 2007-08-08 2012-02-29 Lek Pharmaceuticals D.D. Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323868A (ja) * 1986-07-11 1988-02-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンギオテンシン２受容体遮断性イミダゾ−ル
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
ES2203614T3 (es) 1991-11-18 2004-04-16 E.I. Du Pont De Nemours And Company Intermedios de acido tetrazolilfenilboronico para la sintesis de antagonistas de los receptores de aii.
US5464854A (en) * 1993-11-11 1995-11-07 Depadova; Anathony S. Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S.
CA2179067A1 (en) 1993-12-23 1995-06-29 Gordon Creston Campbell, Jr. Polymorphs of losartan and the process for the preparation of form ii of losartan
CN1101393C (zh) 1996-10-29 2003-02-12 麦克公司 芦沙坦的结晶方法
IT1301759B1 (it) 1998-06-19 2000-07-07 Nicox Sa Sali nitrati di farmaci antiipertensivi

Also Published As

Publication number Publication date
DE60011739D1 (de) 2004-07-29
US6350880B1 (en) 2002-02-26
EP1106611A1 (de) 2001-06-13
ES2218051T3 (es) 2004-11-16
EP1106611B1 (de) 2004-06-23
DE60011739T2 (de) 2005-09-01
JP2001226372A (ja) 2001-08-21

Similar Documents

Publication Publication Date Title
ATE501125T1 (de) Verfahren zur herstellung des calciumsalzes von rosuvastatin
BRPI0412763A (pt) formas anidras, hidratadas ou solvatadas de um composto, forma cristalina, composição farmacêutica, e, método para o tratamento ou a profilaxia de distúrbios
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DE60221619D1 (de) Verfahren zur Reinigung von Synthesegas
DE60126099D1 (de) Kristallines und reines modafinil und verfahren zu seiner herstellung
NL300229I2 (nl) Werkwijze voor het zuiveren van keratinocytgroeifactoren.
DE60114348D1 (de) Verfahren zur Reinigung von Gasen
ATE388135T1 (de) Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen
DE69930469D1 (de) Verfahren und Vorrichtung zur kontinuierlichen Herstellung von wasserfreiem kristallinen Maltitol
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
ATE299885T1 (de) Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung
ATE269858T1 (de) Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan
DE60316791D1 (de) Verfahren zur aufreinigung von lanzoprazol
ATE400560T1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
ID26210A (id) Proses pemurnian turunan sefalosporin
DE60100565D1 (de) Verfahren zur Reinigung von Phosphatidylserin
DE50300917D1 (de) Anlagenteil und verfahren zur zerlegung und reinigung von synthesegas
WO2004075860A3 (en) Process for purification of zoledronic acid
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
ATE459599T1 (de) Gereinigtes lasofoxifen und verfahren zur aufreinigung von racemischem lasofoxifen durch umkristallisieren
DE602006016903D1 (de) Reinigung von Beta-Lactam-Verbindungen
DE60001683T2 (de) Verfahren zur Reinigung von 3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenonsäure
DE60311809D1 (de) Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
DE69510798T2 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties